The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLWB.L Regulatory News (LWB)

  • There is currently no data for LWB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Low & Bonar plc

14 Nov 2019 11:17

Aberforth Partners LLP - Form 8.3 - Low & Bonar plc

Aberforth Partners LLP - Form 8.3 - Low & Bonar plc

PR Newswire

London, November 14

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Aberforth Partners LLP, on behalf of discretionary clients.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Low & Bonar plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 13/11/2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/A NO If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 118,062,916 17.12%00.0
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 118,062,916 17.12%00.0

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 46,551,112 shares included in the total disclosed above. This total includes 40,672,737 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Ordinary SharesSale 50,000 14.2p

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 14 November 2019
Contact name:Michael Campbell, for Aberforth Partners LLP
Telephone number:0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
31st Mar 20157:00 amRNSTotal Voting Rights
26th Mar 20153:46 pmRNSDirector/PDMR Shareholding
26th Mar 201510:49 amRNSDirector/PDMR Shareholding
24th Mar 201512:34 pmRNSResult of AGM
24th Mar 20157:01 amRNSAppointment of NED
24th Mar 20157:00 amRNSInterim Management Statement
23rd Feb 20154:17 pmRNSAnnual Financial Report
6th Feb 20151:56 pmRNSDirector/PDMR Shareholding
6th Feb 20159:06 amRNSHolding(s) in Company
5th Feb 20154:35 pmRNSHolding(s) in Company
3rd Feb 20157:00 amRNSFinal Results
21st Jan 20155:16 pmRNSHolding(s) in Company
11th Dec 20147:00 amRNSTrading Update
9th Dec 201410:41 amRNSHolding(s) in Company
8th Dec 20147:00 amRNSNotice of Trading Update
1st Dec 20141:04 pmRNSTotal Voting Rights
1st Dec 20141:03 pmRNSDirector/PDMR Shareholding
20th Nov 20149:18 amRNSBlocklisting Interim Review
13th Nov 20143:00 pmRNSDirector/PDMR Shareholding
28th Oct 20142:00 pmRNSConsultation Process
15th Oct 20142:35 pmRNSHolding(s) in Company
15th Oct 201411:00 amRNSHolding(s) in Company
15th Oct 20147:00 amRNSInterim Management Statement
14th Oct 201411:52 amRNSNotice of Interim Management Statement
10th Oct 201411:32 amRNSHolding(s) in Company
30th Sep 20147:00 amRNSTotal Voting Rights
25th Sep 201410:04 amRNSDirector Declaration
12th Sep 20143:43 pmRNSDirector/PDMR Shareholding
12th Sep 20143:42 pmRNSDirector/PDMR Shareholding
5th Sep 20147:00 amRNSTrading Update
1st Sep 20147:00 amRNSTotal Voting Rights
26th Aug 20142:00 pmRNSDirector/PDMR Shareholding
26th Aug 201410:38 amRNSHolding(s) in Company
31st Jul 20147:00 amRNSTotal Voting Rights
14th Jul 201411:30 amRNSDirector/PDMR Shareholding
10th Jul 20147:00 amRNSHalf Yearly Report
2nd Jul 20147:33 amRNSDirector Declaration
1st Jul 20149:00 amRNSNotice of Results
30th Jun 20147:00 amRNSTotal Voting Rights
25th Jun 20147:00 amRNSAppointment of Corporate Broker
6th Jun 20147:01 amRNSAppointment of Chief Executive Officer
6th Jun 20147:00 amRNSPre-Close Trading Statement
3rd Jun 20149:29 amRNSTotal Voting Rights
29th May 20144:26 pmRNSDirector/PDMR Shareholding
28th May 20149:30 amRNSBlocklisting Interim Review
27th May 201411:48 amRNSDirector/PDMR Shareholding
15th May 20142:00 pmRNSDirector Declaration
12th May 20143:00 pmRNSDirector Declaration
29th Apr 20142:00 pmRNSDirector/PDMR Shareholding
25th Apr 20147:00 amRNSNotice of Site Visit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.